REGENXBIO INC

RGNXNASDAQ

🏆 #2278 by market capEarnings Nov 4 · PostUS Equity

$133.93▼ $5.93 (−4.43%)

Simulated price

1h—

24h▼ 4.4%

7d—

14d—

30d—

1y—

🏦Market Cap

$703M

Small Cap

📈Revenue Growth (YoY)

+12.0%

Healthy

📊Gross Margin

86.4%

High

💵FCF Margin

18.7%

Healthy

⚖️P/S Ratio

4.0x

Fair

Otter Score

46

Weak

🔭

No analyst ratings for RGNX

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.